Skip to content
Esta página está disponible en españolCambiar →
GestorLensSign up

CH4 Natural Solutions (MTNE): which funds own it

SPAC / vehículos(by SIC code, unreviewed)Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 5, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Follow MTNE for free
Share

Sections with a free account

No concentrated manager holds it.

Who owns CH4 Natural Solutions?

Holders that filed a Schedule 13D or 13G with the SEC for owning more than 5% of the Class A shares: CH4 Natural Solutions Acquisition Sponsor Manager (13G filed Aug 14, 2026), Adage Capital Management (13G filed Aug 12, 2026), Barclays (13G filed Aug 13, 2026) and RP Investment Advisors (13G filed Jul 22, 2026). As of Jun 30, 2026, the largest holders of Class A reported on Form 13F were Adage Capital Partners Gp, L.l.c (8.1% of Class A), Sculptor Capital (5.2%) and Linden Advisors (5.2%).

Which institutions hold the most CH4 Natural Solutions shares?

Per Form 13F filings as of Jun 30, 2026, as a share of Class A:

  1. 1. Adage Capital Partners Gp, L.l.c: 8.1%
  2. 2. Sculptor Capital: 5.2%
  3. 3. Linden Advisors: 5.2%
  4. 4. Magnetar Financial: 5.0%
  5. 5. Polar Asset Management Partners: 4.1%
  6. 6. Heights Capital Management: 3.6%
  7. 7. HBK Investments: 2.7%
  8. 8. Hudson Bay Capital Management: 2.3%
  9. 9. Moore Capital Management: 2.3%
  10. 10. Two Sigma Investments: 1.6%

How much of CH4 Natural Solutions do institutions own?

The 20 institutions that file 13F reported 49.3% of the Class A shares as of Jun 30, 2026.

Sources:13G by CH4 Natural Solutions Acquisition Sponsor Manager (Aug 14, 2026) ↗13G by Adage Capital Management (Aug 12, 2026) ↗13G by Barclays (Aug 13, 2026) ↗13G by RP Investment Advisors (Jul 22, 2026) ↗All of the company's proxy statements on EDGAR ↗

13F percentages divide the shares each institution reports by the Class A shares outstanding on the cover of the company's latest report before the quarter end (Jun 12, 2026). Entities of the same group file separately and are not added up. With more than one share class, a 13D or 13G counts shares convertible from another class as owned, so we do not show its percentage. We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

Concentrated managers
—
All 13F: 20
Consensus
—
No score: it needs 5 or more concentrated managers
Price at Jun 30, 2026 (per 13F)
$9.85
reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Concentrated managers holding it

None in the latest quarter.

Largest holders of MTNE (all 13F filers)

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Fundamentals

Balance sheet only, for now. MTNE has not yet filed its first annual report (10-K) with the SEC, so there are no 12-month figures (revenue, margins, earnings and cash flow). We show the balance sheet from its latest filing; once the 12-month figures are available, this section fills in automatically.

Balance sheet as of Jun 30, 2026
Cash and equivalents
$0
Total debt
$300K
Net debt
$300K
Shareholders' equity
$-14.1M

Balance sheet figures the company filed with the SEC (10-Q or 10-K), in dollars. Net debt = total debt − cash − investments; when negative, the company has more cash than debt (net cash). How each figure is calculated

Insiders (Form 4)

Officers and directors who bought (6 m)
no data
Amount (6 m)
no data
CEO/CFO bought (12 m)
No

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

  • CH4 Natural Solutions Acquisition Sponsor Manager25.5%13Gfiling ↗Event: Jun 30, 2026 · filed: Aug 14, 2026
  • Barclays6.81%13Gfiling ↗Event: Jun 30, 2026 · filed: Aug 13, 2026
  • Adage Capital Management8.11%13Gfiling ↗Event: Jun 30, 2026 · filed: Aug 12, 2026

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

Flagged material events (8-K)

  • May 5, 2026Routinefiling ↗

    Unregistered sale of equity securities (Item 3.02)

  • May 5, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

Alert items the company itself flagged in its 8-K filings with the SEC, most serious first. It is the form's label, with no interpretation from us: Item 5.02 covers routine appointments as well as a chief executive's departure; open the filing. The quoted headline is the original press release's.

All material events (8-K)

Earnings, agreements, financing, management changes and announcements from the last year, with a filter by type and a link to each filing.

Follow MTNE for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow MTNE